RARE Bears bring community together on Rare Disease Day
RARE Bears bring community together on Rare Disease Day
Congenica launches new application to enable faster analysis of epilepsy and neurodevelopmental disorders
Congenica today announced the launch of Congenica Neuro, a new application to enable faster analysis of epilepsy and neurodevelopmental disorders.
Re-annotation of 191 developmental and epileptic encephalopathy-associated genes unmasks de novo variants in SCN1A
Congenica announced the publication of a study on the re-annotation of developmental & epileptic encephalopathy-associated genes with significant clinical implications.
A fast and reliable method to reach a conclusive diagnosis of MYH9-related disorder
Congenica platform provides variant review and assessment to support conclusive diagnoses for patients with complex and commonly misdiagnosed bleeding disorders.
Congenica Appoints Dr. Heiner Dreismann as Non-Executive Director
Congenica Ltd, has announced the appointment of Dr Heiner Dreismann as non-executive Director and Senior Independent Director on the board.
Congenica named MedTech Company of the Year 2019
Congenica has been named MedTech Company of the Year 2019 at the Cambridge Independent Science and Technology Awards 2019 at a ceremony held in Cambridge.
ExomeCG to simplify molecular and cytogenomic data generation and interpretation
Nonacus Ltd has announced the launch of ExomeCG, a new product designed by Congenica to simplify the generation and interpretation of molecular and cytogenomic data.
Prenatal exome sequencing in unexplained fetal oedema: a game changer
Prenatal exome sequencing in unexplained fetal oedema: a game changer
Congenica brings together Mastermind, DECIPHER and Sentieon in major product update
Congenica enables you to achieve 10X faster processing speeds, instantly access genetic evidence and minimize the risk of variants going undetected.
Congenica Integrates Powerful New Curated Data
Congenica has announced the integration of powerful new reference data sources, DECIPHER and Mastermind® into its clinical decision support platform.
Highlights from the International Conference on Prenatal Diagnosis and Therapy
Highlights from the International Conference on Prenatal Diagnosis and Therapy
